Ischemia reperfusion-facilitated sinusoidal endothelial cell injury in liver transplantation and the resulting impact of extravasated platelet aggregation

被引:42
作者
Miyashita, T. [1 ]
Nakanuma, S. [1 ]
Ahmed, A. K. [2 ]
Makino, I. [1 ]
Hayashi, H. [1 ]
Oyama, K. [1 ]
Nakagawara, H. [1 ]
Tajima, H. [1 ]
Takamura, H. [1 ]
Ninomiya, I. [1 ]
Fushida, S. [1 ]
Harmon, J. W. [2 ]
Ohta, T. [1 ]
机构
[1] Kanazawa Univ Hosp, Dept Surg Gastroenterol, 13-1 Takaramachi, Kanazawa, Ishikawa 9208641, Japan
[2] Johns Hopkins Univ, Sch Med, Dept Surg, 4940 Eastern Ave, Baltimore, MD 21224 USA
来源
EUROPEAN SURGERY-ACTA CHIRURGICA AUSTRIACA | 2016年 / 48卷 / 02期
关键词
Ischemia/reperfusion; Extravasated platelet aggregation; Sinusoidal endothelial damage; Antiplatelet agents; Endothelial protection; DISEASE/SINUSOIDAL OBSTRUCTION SYNDROME; HEPATIC STELLATE CELLS; RAT-LIVER; ISCHEMIA/REPERFUSION INJURY; PRECONDITIONING PROTECTS; VENOOCCLUSIVE DISEASE; KUPFFER CELLS; GROWTH-FACTOR; FIBROSIS; THROMBOCYTOPENIA;
D O I
10.1007/s10353-015-0363-3
中图分类号
R61 [外科手术学];
学科分类号
摘要
The exact sequence of events leading to ultimate hepatocellular damage following ischemia/reperfusion (I/R) is incompletely understood. In this article, we review a mechanism of organ dysfunction after hepatic I/R or immunosuppressive treatment, in addition to the potential of liver sinusoidal endothelial cell (LSEC) protection and antiplatelet treatment for the suppression of hepatocellular damage. A review of the literature, utilizing PubMed-NCBI, was used to provide information on the components necessary for the development of hepatocellular damage following I/R. It is well-established that LSECs damage following hepatic I/R or immunosuppressive treatment followed by extravasated platelet aggregation (EPA) is the root cause of organ dysfunction in liver transplantation. We have classified three phases, from LSECs damage to organ dysfunction, utilizing the predicted pathogenic mechanism of sinusoidal obstruction syndrome. The first phase is detachment of LSECs and sinusoidal wall destruction after LSECs injury by hepatic I/R or immunosuppressive treatment. The second phase is EPA, accomplished by sinusoidal wall destruction. The various growth factors, including thromboxane A2, serotonin, transforming growth factor-beta and plasminogen activator inhibitor-1, released by EPA in the Disse's space of zone three, induce portal hypertension and the progression of hepatic fibrosis. The third phase is organ dysfunction following portal hypertension, hepatic fibrosis, and suppressed liver regeneration through various growth factors secreted by EPA. We suggest that EPA in the space of Disse, initiated by LSECs damage due to hepatic I/R or immunosuppressive treatment, and activated platelets may primarily contribute to liver damage in liver transplantation. Endothelial protective therapy or antiplatelet treatment may be useful in the treatment of hepatic I/R following EPA.
引用
收藏
页码:92 / 98
页数:7
相关论文
共 60 条
  • [1] Regulation of ecto-apyrase CD39 (ENTPD1) expression by phosphodiesterase III (PDE3)
    Baek, Amy E.
    Kanthi, Yogendra
    Sutton, Nadia R.
    Liao, Hui
    Pinsky, David J.
    [J]. FASEB JOURNAL, 2013, 27 (11) : 4419 - 4428
  • [2] SUPPORT OF CULTURED-HEPATOCYTES BY A LAMININ-RICH GEL - EVIDENCE FOR A FUNCTIONALLY SIGNIFICANT SUBENDOTHELIAL MATRIX IN NORMAL RAT-LIVER
    BISSELL, DM
    ARENSON, DM
    MAHER, JJ
    ROLL, FJ
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1987, 79 (03) : 801 - 812
  • [3] Transjugular intrahepatic portosystemic shunt for the treatment of sinusoidal obstruction syndrome in a liver transplant recipient and review of the literature
    Campos-Varela, Isabel
    Castells, Lluis
    Dopazo, Cristina
    Perez-Lafuente, Mercedes
    Allende, Helena
    Len, Oscar
    Llopart, Lluis
    Vargas, Victor
    Charco, Ramon
    [J]. LIVER TRANSPLANTATION, 2012, 18 (02) : 201 - 205
  • [4] How I treat sinusoidal obstruction syndrome
    Chao, Nelson
    [J]. BLOOD, 2014, 123 (26) : 4023 - 4026
  • [5] Hepatic stellate cell activation and hepatic fibrosis induced by ischemia/reperfusion injury
    Cheng, F.
    Li, Y.
    Feng, L.
    Li, S.
    [J]. TRANSPLANTATION PROCEEDINGS, 2008, 40 (07) : 2167 - 2170
  • [6] CHINTALA MS, 1994, J PHARMACOL EXP THER, V271, P1203
  • [7] CXC chemokines play a critical role in liver injury, recovery, and regeneration
    Clarke, Callisia N.
    Kuboki, Satoshi
    Tevar, Amit
    Lentsch, Alex B.
    Edwards, Michael
    [J]. AMERICAN JOURNAL OF SURGERY, 2009, 198 (03) : 415 - 419
  • [8] Liver HIF-1 alpha induction precedes apoptosis following normothermic ischemia-reperfusion in rats
    Cursio, R.
    Miele, C.
    Filippa, N.
    Van Obberghen, E.
    Gugenheim, J.
    [J]. TRANSPLANTATION PROCEEDINGS, 2008, 40 (06) : 2042 - 2045
  • [9] ROLE OF PLATELETS IN HEPATIC ALLOGRAFT PRESERVATION INJURY IN THE RAT
    CYWES, R
    PACKHAM, MA
    TIETZE, L
    SANABRIA, JR
    HARVEY, PRC
    PHILLIPS, MJ
    STRASBERG, SM
    [J]. HEPATOLOGY, 1993, 18 (03) : 635 - 647
  • [10] Mesenchymal stromal cells in renal ischemia/reperfusion injury
    de Vries, Dorottya K.
    Schaapherder, Alexander F. M.
    Reinders, Marlies E. J.
    [J]. FRONTIERS IN IMMUNOLOGY, 2012, 3